The Global Drug Screening Market is segmented on the lines of its technology, treatment, application and regional. On the basis of product and service it is segmented as Equipment further equipment includes Immunoassay Analyzers, Chromatography Instruments, Breath Analyzers and breath analyzers include Fuel Cell Breath alyzers, Semiconductor Breathalyzers, and Other Devices. It is further segmented as Rapid Testing Devices in that it covers Urine Testing Devices it includes Drug Test Cups, Dip Cards, Cassettes, Oral Fluid Testing Devices and again it is segmented as Consumables in consumables it involves Assay kits, Sample Collection Cups, Calibrators and Controls, Others and Laboratory Services. On the basis of sample it includes Urine, Breath, Oral Fluid, Blood, Others (Hair and Sweat). Further it is segmented on end users as Workplaces and schools, Law enforcement agencies and criminal justice systems, Personal users, Drug treatment centers, Pain management centers, Hospitals and Drug testing laboratories. The Global Drug Screening Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
You can browse full report:https://www.marketresearchengine.com/drug-screening-market
The scope of the report includes a detailed study of global and regional markets on Drug Screening Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Thermo Fisher Scientific, Inc. (U.S.), Laboratory Corporation of America Holdings (U.S.), Alere, Inc., (U.S.),Quest Diagnostics (U.S.), Roche Diagnostics (Switzerland), Drägerwerk AG & Co. KGaA (Germany), Siemens Healthcare (Germany), Express Diagnostics Int’l Inc. (U.S.), Shimadzu (Japan), and MPD, Inc. (U.S.). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Global Drug Screening Market is expected to exceed more than US$ 9.50 Billion by 2024 at a CAGR of 9.5% in the given forecast period.
Drug screening is used for distinguishing supported and furthermore unlawful prescriptions in blood, urine, and other biological samples generally at hospitals, trained athletes, places of employment, schools and post-mishap. It is considered as a fundamental bit of nonstop assurance and treatment, can be by reason or irregular. Drug screening is done at the period of some suspicious reason, all things considered before sports events or employment. Drug screening is also done if the patient is not in a condition to speak or is unconscious it is also done to understand the allergies due to use of drugs.
This report provides:
1) An overview of the global market for Drug Screening Marketand related technologies.
2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for Drug Screening Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
The major driving factors of Global Drug Screening Market are as follows:Growing aging population Initiatives for drug screening and growth in government funding Growing knowledge and awareness about drug screening among developing economies Rise in alcohol and drug abuse Drug addicts
The restraining factors of Global Drug Screening Market are as follows:Accuracy issues related to breath alyzers In Some countries drug screening is Considered as A Violation of Privacy Rights Consumption of alcohol is banned in some countries
The Global Drug Screening Market has been segmented as below:
The Global Drug Screening Market is Segmented on the lines of Product and Service Analysis, Sample Analysis, End User Analysis and Regional Analysis. By Product and Service Analysisthis market is segmented on the basis ofEquipment, Rapid Testing Devices, Consumables and Laboratory Services. Equipment its covers Immunoassay Analyzers, Chromatography Instruments and Breath Analyzers its covers like Fuel Cell Breathalyzers, Semiconductor Breathalyzers and Other Devices. Rapid Testing Devices its covers Urine Testing Devices its covers like Drug Test Cups, Dip Cards, Cassettes. And Oral Fluid Testing Devices. Consumables its covers Assay kits, Sample Collection Cups, Calibrators and Controls and Others.
By Sample Analysis this market is segmented on the basis ofUrine, Breath, Oral Fluid, Blood and Others (Hair and Sweat). By End User Analysis this market is segmented on the basis ofWorkplaces and schools sector, Law enforcement agencies and criminal justice systems sector, Personal users sector, Drug treatment centers sector, Pain management centers sector, Hospitals sector and Drug testing laboratories sector. By Regional Analysis this market is segmented on the basis ofNorth America, Europe, Asia-Pacific and Rest of the World.
Request Sample Report from here:https://www.marketresearchengine.com/drug-screening-market
Table of Contents
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
8 Drug and Alcohol Testing Market, By Sample Type
9 Drug and Alcohol Testing Market, By End Users
10 Geographic Analysis
11 Competitive Landscape
12 Company Profiles
12.1 Drägerwerk AG & Co. KGAA
12.2 Alere, Inc.
12.3 Express Diagnostics Int’l, Inc.
12.4 Laboratory Corporation of America
12.5 MPD, Inc.
12.6 Quest Diagnostics
12.7 Roche Diagnostics
12.8 Shimadzu, Corp.
12.9 Siemens Healthcare
12.1 Thermo Fisher Scientific, Inc.
Other Related Market News :
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States